Back

Sex specific associations between serum uric acid levels and risk of hypertension for different reference values of high blood pressure

26 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Challenges in hypertension management and gender aspects Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Anwar Salim

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima (Japan)

6 More presentations in this session

Presentation thumbnail
Adherence to ESC guidelines for antihypertensive drug therapy: real-world survey from an EU country
Mr M. Selvek (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Ten year follow-up study regarding treatment compliance and cardiovascular events in young first diagnosed and never treated hypertensives of a European Society of Hypertension Excellence Center
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Therapeutic inertia in the management of hypertension by moroccan general practitioners
Doctor B. Aloutmani (Oujda, MA)
Abstract Slides
Presentation thumbnail
Sex differences in individuals with high normal blood pressure who developed hypertension in three-year follow-up
Mr T. Kalos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
High-normal systolic blood pressure in early midlife is a stronger risk factor for incident hypertension later in life for women than men.
Doctor E. Kringeland (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension management and gender aspects

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Should sex differences be considered in hypertension management?
thumbnail
Congress Presentation
Sacubitril/Allisartan in hyperuricemia
thumbnail
Congress Presentation
Sex-based differences in the impact of baseline plasma uricemia on long-term mortality risk following acute coronary syndrome: a 26-year follow-up study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources